These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 24553882)
41. Are Allogeneic Transfusions Decreasing in Total Knee Arthroplasty Patients? National Inpatient Sample 2009-2013. Mistry JB; Gwam CU; Naziri Q; Pivec R; Abraham R; Mont MA; Delanois RE J Arthroplasty; 2018 Jun; 33(6):1705-1712. PubMed ID: 29352682 [TBL] [Abstract][Full Text] [Related]
42. National trends in the utilization of blood transfusions in total hip and knee arthroplasty. Yoshihara H; Yoneoka D J Arthroplasty; 2014 Oct; 29(10):1932-7. PubMed ID: 24890994 [TBL] [Abstract][Full Text] [Related]
43. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Strümper D; Weber EW; Gielen-Wijffels S; Van Drumpt R; Bulstra S; Slappendel R; Durieux ME; Marcus MA Transfusion; 2004 Nov; 44(11):1567-71. PubMed ID: 15504161 [TBL] [Abstract][Full Text] [Related]
44. The influence of chronic kidney disease on the duration of hospitalisation and transfusion rate after elective hip and knee arthroplasty. Kaiser C; Tillmann FP; Löchter J; Landgraeber S; Jäger M Int Urol Nephrol; 2019 Jan; 51(1):147-153. PubMed ID: 30324577 [TBL] [Abstract][Full Text] [Related]
45. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. Phillips CB; Barrett JA; Losina E; Mahomed NN; Lingard EA; Guadagnoli E; Baron JA; Harris WH; Poss R; Katz JN J Bone Joint Surg Am; 2003 Jan; 85(1):20-6. PubMed ID: 12533567 [TBL] [Abstract][Full Text] [Related]
46. Blood transfusion and cytokines' changes in total knee replacement. Drosos GI; Blatsoukas KS; Ververidis A; Tripsianis G; Chloropoulou P; Iatrou C; Kazakos K; Verettas DA Arch Orthop Trauma Surg; 2012 Oct; 132(10):1505-13. PubMed ID: 22718076 [TBL] [Abstract][Full Text] [Related]
47. A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis. Chahal GS; Saithna A; Brewster M; Gilbody J; Lever S; Khan WS; Foguet P Ortop Traumatol Rehabil; 2013; 15(2):125-9. PubMed ID: 23652532 [TBL] [Abstract][Full Text] [Related]
48. Effect of Body Mass Index on Blood Transfusion in Total Hip and Knee Arthroplasty. Frisch N; Wessell NM; Charters M; Peterson E; Cann B; Greenstein A; Silverton CD Orthopedics; 2016 Sep; 39(5):e844-9. PubMed ID: 27172370 [TBL] [Abstract][Full Text] [Related]
49. Incidence and Risk Factors for Blood Transfusion in Simultaneous Bilateral Total Joint Arthroplasty: A Multicenter Retrospective Study. Cao G; Huang Z; Huang Q; Zhang S; Xu B; Pei F J Arthroplasty; 2018 Jul; 33(7):2087-2091. PubMed ID: 29525340 [TBL] [Abstract][Full Text] [Related]
50. Autologous blood transfusion does not reduce postoperative infection rates in elective surgery. Sauaia A; Alexander W; Moore EE; Stevens BR; Rosen H; Dunn TR Am J Surg; 1999 Dec; 178(6):549-55. PubMed ID: 10670870 [TBL] [Abstract][Full Text] [Related]
51. Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. Grosvenor D; Goyal V; Goodman S J Bone Joint Surg Am; 2000 Jul; 82-A(7):951-4. PubMed ID: 10901309 [TBL] [Abstract][Full Text] [Related]
52. Incidence and Risk Factors for Blood Transfusion in Total Joint Arthroplasty: Analysis of a Statewide Database. Slover J; Lavery JA; Schwarzkopf R; Iorio R; Bosco J; Gold HT J Arthroplasty; 2017 Sep; 32(9):2684-2687.e1. PubMed ID: 28579446 [TBL] [Abstract][Full Text] [Related]
53. Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty. Basora M; Pereira A; Soriano A; Martínez-Pastor JC; Sánchez-Etayo G; Tió M; Salazar F Vox Sang; 2010 Feb; 98(2):124-9. PubMed ID: 19754522 [TBL] [Abstract][Full Text] [Related]
55. Risk Factors for Transfusions Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis. Salt E; Wiggins AT; Rayens MK; Brown K; Eckmann K; Johannemann A; Wright RD; Crofford LJ J Clin Rheumatol; 2018 Dec; 24(8):422-426. PubMed ID: 29538083 [TBL] [Abstract][Full Text] [Related]
56. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942 [TBL] [Abstract][Full Text] [Related]
57. Postoperative autologous blood salvage drains--are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases. Jones HW; Savage L; White C; Goddard R; Lumley H; Kashif F; Gurusany K Acta Orthop Belg; 2004 Oct; 70(5):466-73. PubMed ID: 15587036 [TBL] [Abstract][Full Text] [Related]
58. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Guerin S; Collins C; Kapoor H; McClean I; Collins D Transfus Med; 2007 Feb; 17(1):37-43. PubMed ID: 17266702 [TBL] [Abstract][Full Text] [Related]
59. Two-year experience with cell salvage in total hip arthroplasty. Buget MI; Dikici F; Edipoğlu İS; Yıldız E; Valiyev N; Kucukay S Braz J Anesthesiol; 2016; 66(3):276-82. PubMed ID: 27108825 [TBL] [Abstract][Full Text] [Related]
60. Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay. Frietsch T; Karger R; Schöler M; Huber D; Bruckner T; Kretschmer V; Schmidt S; Leidinger W; Weiler-Lorentz A Transfusion; 2008 Oct; 48(10):2133-42. PubMed ID: 18564391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]